RMTG (Regenerative Medical Technology Group) Total Stockholders Equity : $-27.36 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group Total Stockholders Equity?

Regenerative Medical Technology Group's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $-27.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Regenerative Medical Technology Group's Book Value per Share for the quarter that ended in Dec. 2024 was $-2.18. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Regenerative Medical Technology Group's Debt-to-Equity for the quarter that ended in Dec. 2024 was -0.73.

Regenerative Medical Technology Group Total Stockholders Equity Historical Data

The historical data trend for Regenerative Medical Technology Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group Total Stockholders Equity Chart

Regenerative Medical Technology Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

-6.41

-6.76

-11.98

-21.80

-27.36

Regenerative Medical Technology Group Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial															-21.80	-23.76	-25.83	-26.72	-27.36

Regenerative Medical Technology Group (OTCPK:RMTG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Regenerative Medical Technology Group's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-27.357	-	0.001)	/	12.539
	=	-2.18

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Regenerative Medical Technology Group's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(17.837	+	2.212)	/	-27.357
	=	-0.73

Regenerative Medical Technology Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803